Landmark Bio is a contract development and manufacturing organization (CDMO) focused on cell and gene therapy. It provides end-to-end services including drug development consulting, process analytical development, cGMP manufacturing, and CMC regulatory consulting to turn research into clinical programs. Its offerings are tailored services rather than products, delivered through collaborations with academia, physicians, biopharma, and research hospitals to address manufacturing costs and complexities. Its goal is to help programs reach clinical trials and commercial use faster while meeting regulatory standards and budget constraints, increasing patient access to advanced therapies.
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Watertown, Massachusetts
Founded
N/A
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?